Cannabis - Aspectos regulatorios: políticas y regulación
Cannabis: políticas de drogas y regulación
- Fuente: PubMed [Internet]. Bethesda (MD): US National Library of Medicine National Institutes of Health; [consulta 25 mayo 2022]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/
- Detalles de búsqueda: ((("cannabis"[MeSH Terms] OR "cannabis"[All Fields]) AND ("legal"[All Fields] OR "legalism"[All Fields] OR "legalities"[All Fields] OR "legality"[All Fields] OR "legalization"[All Fields] OR "legalize"[All Fields] OR "legalized"[All Fields] OR "legalizes"[All Fields] OR "legalizing"[All Fields] OR "legally"[All Fields]) AND "drug policy"[All Fields]) NOT ("economics"[MeSH Subheading] OR "economics"[All Fields] OR "economics"[MeSH Terms])) AND (y_5[Filter])
2022
- Ventresca M, Elliott C. Cannabis edibles packaging: Communicative objects in a growing market. Int J Drug Policy. mayo de 2022;103:103645.
- Lazor T, Blondal E, Scheim A, Cubillos P, Werb D, Milloy M-J, et al. Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains. Drug Alcohol Depend. 15 de abril de 2022;236:109463.
- Kilmer B, Rivera-Aguirre A, Queirolo R, Ramirez J, Cerdá M. Cannabis legalization and traffic injuries: exploring the role of supply mechanisms. Addiction. 7 de febrero de 2022.
- Wu G, Li Y, Eric Lang X. Effects of recreational marijuana legalization on clearance rates for violent crimes: Evidence from Oregon. Int J Drug Policy. febrero de 2022;100:103528.
- Vann B. Direct democracy and the adoption of recreational marijuana legalization in the United States, 2012-2019. Int J Drug Policy. 4 de febrero de 2022;102:103583.
- Okey SA, Castro SA, Waddell JT, Jones CB, Blake AJ, O’Rourke HP, et al. Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020. Int J Drug Policy. febrero de 2022;100:103531.
- Espinosa S, Marks C, Fondevila G. Identifying archetypal cannabis consumers to inform drug policy design: a Q-sort assessment of young adults’ attitudes in Mexico City’s metropolitan area. J Cannabis Res. 8 de enero de 2022;4(1):5.
2021
- Bourdon JL, Francis MW, Jia L, Liang C, Robinson HI, Grucza RA. The effect of cannabis policies on treatment outcomes for cannabis use among U.S. adults. J Subst Abuse Treat. diciembre de 2021;131:108535.
- Leas EC, Nobles AL, Shi Y, Hendrickson E. Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use. Int J Drug Policy. 21 de diciembre de 2021;101:103557.
- Quednow BB, Steinhoff A, Bechtiger L, Ribeaud D, Eisner M, Shanahan L. High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland. Eur Addict Res. 3 de diciembre de 2021;1-13.
- Qatanani A, Umar M, Padela AI. Bioethical insights from the Fiqh Council of North America’s recent ruling on medical cannabis. Int J Drug Policy. noviembre de 2021;97:103360.
- Perkins D, Brophy H, McGregor IS, O’Brien P, Quilter J, McNamara L, et al. Medicinal cannabis and driving: the intersection of health and road safety policy. Int J Drug Policy. noviembre de 2021;97:103307.
- Crépault J-F, Rehm J, Room R. Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada. Int J Drug Policy. noviembre de 2021;97:103367.
- Adams PJ, Rychert M, Wilkins C. Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries. Addiction. noviembre de 2021;116(11):2939-46.
- Adams PJ, Rychert M, Wilkins C. How does the influence of the cannabis industry differ from that of alcohol and tobacco? Addiction. noviembre de 2021;116(11):2951-2.
- Goundar P, Macaulay T, Szafron M. A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America. Int J Drug Policy. agosto de 2021;94:103191.
- Caulkins JP. Radical technological breakthroughs in drugs and drug markets: The cases of cannabis and fentanyl. Int J Drug Policy. agosto de 2021;94:103162.
- Winstock AR, Lynskey MT, Maier LJ, Ferris JA, Davies EL. Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada. Int J Drug Policy. mayo de 2021;91:102789.
- Obradovic I. From prohibition to regulation: A comparative analysis of the emergence and related outcomes of new legal cannabis policy models (Colorado, Washington State and Uruguay). Int J Drug Policy. mayo de 2021;91:102590.
- Boyd N, Sevigny EL. Strategic innovations in cannabis legalization policy: Lessons from early adopters. Int J Drug Policy. mayo de 2021;91:103193.
2020
- Fink DS, Stohl M, Sarvet AL, Cerdà M, Keyes KM, Hasin DS. Medical marijuana laws and driving under the influence of marijuana and alcohol. Addiction. octubre de 2020;115(10):1944-53.
- Scheim AI, Maghsoudi N, Marshall Z, Churchill S, Ziegler C, Werb D. Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review. BMJ Open. 21 de septiembre de 2020;10(9):e035148.
- Santaella-Tenorio J, Wheeler-Martin K, DiMaggio CJ, Castillo-Carniglia A, Keyes KM, Hasin D, Cerdà M. Association of Recreational Cannabis Laws in Colorado and Washington State With Changes in Traffic Fatalities, 2005-2017. JAMA Intern Med. 1 de agosto de 2020;180(8):1061-8.
- Laqueur H, Rivera-Aguirre A, Shev A, Castillo-Carniglia A, Rudolph KE, Ramirez J, et al. The impact of cannabis legalization in Uruguay on adolescent cannabis use. Int J Drug Policy. junio de 2020;80:102748.
- Takakuwa KM. A history of the Society of Cannabis Clinicians and its contributions and impact on the US medical cannabis movement. Int J Drug Policy. 11 de abril de 2020;79:102749.
- Hammond D, Goodman S, Wadsworth E, Rynard V, Boudreau C, Hall W. Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. Int J Drug Policy. 26 de febrero de 2020;77:102698.
- Fischer B, Bullen C. Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization. Int J Drug Policy. febrero de 2020;76:102632.
- Greer A, Ritter A. The legal regulation of drugs and role of government: Perspectives from people who use drugs. Drug Alcohol Depend. 1 de enero de 2020;206:107737.
- Frendreis J, Tatalovich R. Postmaterialism and referenda voting to legalize marijuana. Int J Drug Policy. enero de 2020;75:102595.
- Midgette G, Reuter P. Has Cannabis Use Among Youth Increased After Changes in Its Legal Status? A Commentary on Use of Monitoring the Future for Analyses of Changes in State Cannabis Laws. Prev Sci. enero de 2020;21(1):137-45 .
2019
- Gagnon M, Guta A. Cannabis legalization in Canada: What are the potential implications and barriers for people living with HIV? Int J Drug Policy. diciembre de 2019;74:191-2.
- Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644-63.
- Melchior M, Nakamura A, Bolze C, Hausfater F, El Khoury F, Mary-Krause M, et al. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis. BMJ Open. 10 de julio de 2019;9(7):e025880.
- Caulkins JP, Davenport S, Doanvo A, Furlong K, Siddique A, Turner M, et al. Triangulating web & general population surveys: Do results match legal cannabis market sales? Int J Drug Policy. 1 de julio de 2019;
- Caulkins JP, Kilborn ML. Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials. Am J Drug Alcohol Abuse. 28 de mayo de 2019;1-9.
- Chihuri S, Li G. State marijuana laws and opioid overdose mortality. Inj Epidemiol. 2019;6:38.
- Kilmer B. How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps. Am J Drug Alcohol Abuse. 2 de julio de 2019;1-9.
- Mahamad S, Hammond D. Retail price and availability of illicit cannabis in Canada. Addict Behav. marzo de 2019;90:402-8.
- Wadsworth E, Hammond D. International differences in patterns of cannabis use among youth: Prevalence, perceptions of harm, and driving under the influence in Canada, England & United States. Addict Behav. marzo de 2019;90:171-5.
- Watson TM, Hyshka E, Bonato S, Rueda S. Early-Stage Cannabis Regulatory Policy Planning Across Canada’s Four Largest Provinces: A Descriptive Overview. Subst Use Misuse. 2019;54(10):1691-704.
2018
- Bewley-Taylor DR. Canada, cannabis legalization and uncertainty around the United Nations drug control conventions. Addiction. julio de 2018;113(7):1226-8.
- Caulkins JP, Bao Y, Davenport S, Fahli I, Guo Y, Kinnard K, et al. Big data on a big new market: Insights from Washington State’s legal cannabis market. Int J Drug Policy. 2018;57:86-94.
- Caulkins JP. In praise of flawed treaties. Addiction. julio de 2018;113(7):1224-5.
- Cox C. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. Health Policy. 2018;122(3):205-9.
- Crépault J-F. Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances. Front Public Health. 2018;6:220.
- George TP, Hill KP, Vaccarino FJ. Cannabis Legalization and Psychiatric Disorders: Caveat «Hemp-tor». Can J Psychiatry. 2018;63(7):447-50.
- Hall W. Imperfect international treaties interpreted flexibly are likely to be better than no treaties. Addiction. julio de 2018;113(7):1230.
- Rolles S. The different outcomes of legislative- versus advocacy-led development of cannabis policy. Addiction. abril de 2018;113(4):606-7.
2017
- Bear D. From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada. Int J Drug Policy. 2017;42:97-101.
- Borodovsky JT, Budney AJ. Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship? Int J Drug Policy. 2017;50:102-10 .
- Carlini BH. Potency increase, product development and marijuana marketing in times of legalization. Addiction. 2017;112(12):2178-9.
- Cerdà M, Kilmer B. Uruguay’s middle-ground approach to cannabis legalization. Int J Drug Policy. 2017;42:118-20.
- Gourdet C, Giombi KC, Kosa K, Wiley J, Cates S. How four U.S. states are regulating recreational marijuana edibles. Int J Drug Policy. 2017;43:83-90 .
- Havemann-Reinecke U, Hoch E, Preuss UW, Kiefer F, Batra A, Gerlinger G, et al. [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]. Nervenarzt. marzo de 2017;88(3):291-8.
- Kilmer B, Pacula RL. Building the data infrastructure to evaluate cannabis legalization. Addiction. 2017;112(7):1140-1.
- Kilmer B, Pacula RL. Understanding and learning from the diversification of cannabis supply laws. Addiction. julio de 2017;112(7):1128-35.
- Kilmer B. Recreational Cannabis - Minimizing the Health Risks from Legalization. N Engl J Med. 23 de febrero de 2017;376(8):705-7.
- Mark K, Terplan M. Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization. Prev Med. noviembre de 2017;104:46-9.
- Mendiburo-Seguel A, Vargas S, Oyanedel JC, Torres F, Vergara E, Hough M. Attitudes towards drug policies in Latin America: Results from a Latin-American Survey. Int J Drug Policy. 2017;41:8-13.
- Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. diciembre de 2017;112(12):2167-77.
2016
- Bretteville-Jensen AL. Expected lessons from the US experience with alternative cannabis policy regimes. Addiction. 2016;111(12):2090-1 .
- Caulkins JP, Kilmer B. Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont. Addiction. 2016;111(12):2082-9.
- Caulkins JP, Kilmer B. The US as an example of how not to legalize marijuana? Addiction. 2016;111(12):2095-6.
- Hajizadeh M. Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts. Int J Health Policy Manag. 25 de mayo de 2016;5(8):453-6 .
- Kalant H. A critique of cannabis legalization proposals in Canada. Int J Drug Policy. 2016;34:5-10.
- Pacula RL, Jacobson M, Maksabedian EJ. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016;111(6):973-80.
- von Hoffmann J. The international dimension of drug policy reform in Uruguay. Int J Drug Policy. 2016;34:27-33.
2015
2014
- Kilmer B. Policy designs for cannabis legalization: starting with the eight Ps. Am J Drug Alcohol Abuse. julio de 2014;40(4):259-61.
- Palamar JJ. An examination of opinions toward marijuana policies among high school seniors in the United States. J Psychoactive Drugs. diciembre de 2014;46(5):351-61.
